Silihan lan utang jangka dawa perusahaan: Theratechnologies Inc (THTX)

Theratechnologies Inc. specializes in developing medications for people living with HIV. This chart on GURU.Markets confirms the company's strong pricing power within the rare disease niche, where the indicator stands at 0.00. Patent protections and FDA certifications create an insurmountable barrier to entry for new players. However, geopolitical instability and supply chain disruptions could slow the progress of global medical trials.

This indicator aggregates all liabilities with a maturity exceeding twelve months, reflecting the long-term financing structure. The metric allows for an assessment of capital stability and debt service risks over the long term. For Theratechnologies Inc. (THTX), debt control is critical when implementing monopoly pricing power for lipodystrophy drugs. The trend in the organization's long-term financial debt reflects a balance between innovation investments and solvency.